• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性拮抗剂(CH-38083和吲哚哌唑)无法区分突触前和突触后α2-肾上腺素能受体。

Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.

作者信息

Lonart G, Harsing L G, Folly G, Vizi E S

机构信息

Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest.

出版信息

J Auton Pharmacol. 1989 Apr;9(2):149-58. doi: 10.1111/j.1474-8673.1989.tb00206.x.

DOI:10.1111/j.1474-8673.1989.tb00206.x
PMID:2565902
Abstract
  1. The prejunctional alpha 2-adrenoreceptor antagonist activity of CH-38083 (7,8-(methylenedioxi)-14-alpha-hydroxyalloberbane HCl), idazoxan and prazosin was determined against B-HT 920 on the tachycardia induced by cardiac nerve stimulation in pithed rats. Antagonism of cirazoline and B-HT 920 pressor responses was used to assess postjunctional alpha 1- and alpha 2-adrenoreceptor antagonist activities. 2. CH-38083 was more potent than idazoxan in blocking pre- and postjunctional alpha 2-adrenoreceptor sites. There was no difference between the activities of the two selective alpha 2-adrenoreceptor blocking agents on pre- and postjunctional alpha 2-adrenoreceptors. 3. These data classify CH-38083 as a potent and highly selective alpha 2-adrenoreceptor antagonist in vivo and further support evidence of the homogeneity of pre- and postjunctional alpha 2-adrenoreceptors.
摘要
  1. 在去脑大鼠中,测定了CH-38083(7,8-亚甲基二氧-14-α-羟基别隐品碱盐酸盐)、咪唑克生和哌唑嗪对B-HT 920所致心脏神经刺激诱发心动过速的节前α2-肾上腺素能受体拮抗剂活性。用可乐定和B-HT 920升压反应的拮抗作用来评估节后α1-和α2-肾上腺素能受体拮抗剂活性。2. CH-38083在阻断节前和节后α2-肾上腺素能受体位点方面比咪唑克生更有效。两种选择性α2-肾上腺素能受体阻断剂在节前和节后α2-肾上腺素能受体上的活性没有差异。3. 这些数据将CH-38083归类为体内一种强效且高度选择性的α2-肾上腺素能受体拮抗剂,并进一步支持节前和节后α2-肾上腺素能受体同质性的证据。

相似文献

1
Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.选择性拮抗剂(CH-38083和吲哚哌唑)无法区分突触前和突触后α2-肾上腺素能受体。
J Auton Pharmacol. 1989 Apr;9(2):149-58. doi: 10.1111/j.1474-8673.1989.tb00206.x.
2
Effect of CH-38083, a selective antagonist of alpha 2-adrenoceptors, on renal sympathetic function.α2肾上腺素能受体选择性拮抗剂CH-38083对肾交感神经功能的影响。
Neuropharmacology. 1989 Feb;28(2):135-40. doi: 10.1016/0028-3908(89)90049-x.
3
Idazoxan and CH-38083 affect gastric secretion by inhibiting alpha-2 adrenoceptors at vagal and sympathetic pathways.
Acta Physiol Hung. 1990;75 Suppl:81-2.
4
Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.α2-肾上腺素能受体拮抗剂伊达唑烷(RX 781094)的2-烷基类似物在外周系统中的选择性和效价。
Br J Pharmacol. 1984 Nov;83(3):713-22. doi: 10.1111/j.1476-5381.1984.tb16225.x.
5
CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.CH-38083,一种α-2肾上腺素能受体的选择性强效拮抗剂。
J Pharmacol Exp Ther. 1986 Aug;238(2):701-6.
6
Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.咪唑克生对映体的药理特性:其α-肾上腺素受体阻断作用之间可能的分离
Clin Exp Hypertens A. 1986;8(3):387-409. doi: 10.3109/10641968609039612.
7
The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Clin Pharmacol Ther. 1984 Aug;36(2):190-6. doi: 10.1038/clpt.1984.161.
8
Cardiac alpha-adrenoceptors: postjunctional and prejunctional.心脏α-肾上腺素能受体:突触后和突触前的。
J Mol Cell Cardiol. 1986 Nov;18 Suppl 5:17-32. doi: 10.1016/s0022-2828(86)80458-8.
9
Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.RX 781094的研究:一种α2肾上腺素能受体的选择性、强效且特异性拮抗剂。
Br J Pharmacol. 1983 Mar;78(3):489-505. doi: 10.1111/j.1476-5381.1983.tb08809.x.
10
Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
Psychopharmacology (Berl). 1989;99(1):117-21. doi: 10.1007/BF00634464.